Intracellular delivery of antibodies using TAT fusion protein A

Biochemical and Biophysical Research Communications

Volumn 310, Issue 3, 2003, Pages 730-734

  Mie, Masayasu ^a   Takahashi, Fumio ^a   Funabashi, Hisakage ^a   Yanagida, Yasuko ^a   Aizawa, Masuo ^a   Kobatake, Eiry ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Antibody; Protein transduction; Staphylococcal protein A; TAT

Indexed keywords

ANTIBODY; FLUORESCENT DYE; HYBRID PROTEIN; IMMUNOGLOBULIN G; REAGENT; STAPHYLOCOCCUS PROTEIN A; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANTIBODY LABELING; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; INTERNALIZATION; INTRACELLULAR TRANSPORT; METHODOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; RABBIT; TIME;

HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0141645444     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.071     Document Type: Article

References (24)

1. Maciejewski J.P., Weichold F.F., Young N.S., Cara A., Zella D., Reitz M.S. Jr., Gallo R.C. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat. Med. 1:1995;667-673.
2. Cochet O., Kenigsberg M., Delumeau I., Virone-Oddos A., Multon M.C., Fridman W.H., Schweighoffer F., Teillaud J.L., Tocque B. Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression. Cancer Res. 58:1998;1170-1176.
3. Chakrabarti R., Wylie D.E., Schuster S.M. Transfer of monoclonal antibodies into mammalian cells by electroporation. J. Biol. Chem. 264:1989;15494-15500.
4. Biocca S., Pierandrei-Amaldi P., Cattaneo A. Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of Xenopus oocytes. Biochem. Biophys. Res. Commun. 197:1993;422-427.
5. Arnheiter H., Haller O. Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins. EMBO J. 7:1988;1315-1320.
6. Niesner U., Halin C., Lozzi L., Gunthert M., Neri P., Wunderli-Allenspach H., Zardi L., Neri D. Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides. Bioconjug. Chem. 13:2002;729-736.
7. Zhao Y., Lou D., Burkett J., Kohler H. Chemical engineering of cell penetrating antibodies. J. Immunol. Methods. 254:2001;137-145.
8. Morris M.C., Depollier J., Mery J., Heitz F., Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19:2001;1173-1176.
9. Mann D.A., Frankel A.D. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10:1991;1733-1739.
10. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA. 91:1994;664-668.
11. Vives E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:1997;16010-16017.
12. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269:1994;10444-10450.
13. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88:1997;223-233.
14. Nagahara H., Ezhevsky S.A., Vocero-Akbani A.M., Kaldis P., Solomon M.J., Dowdy S.F. Transforming growth factor beta targeted inactivation of cyclin E:cyclin-dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity. Proc. Natl. Acad. Sci. USA. 96:1999;14961-14966.
15. Phelan A., Elliott G., O'Hare P. Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat. Biotechnol. 16:1998;440-443.
16. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1999;1569-1572.
17. Goding J.W. Use of staphylococcal protein A as an immunological reagent. J. Immunol. Methods. 20:1978;241-253.
18. Hjelm H., Hjelm K., Sjoquist J. Protein A from Staphylococcus aureus. Its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins. FEBS Lett. 28:1972;73-76.
19. Kanno S., Yanagida Y., Haruyama T., Kobatake E., Aizawa M. Assembling of engineered IgG-binding protein on gold surface for highly oriented antibody immobilization. J. Biotechnol. 76:2000;207-214.
20. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278:2003;585-590.
21. Lundberg M., Johansson M. Is VP22 nuclear homing an artifact? Nat. Biotechnol. 19:2001;713-714.
22. Lundberg M., Johansson M. Positively charged DNA-binding proteins cause apparent cell membrane translocation. Biochem. Biophys. Res. Commun. 291:2002;367-371.
23. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277:2002;2437-2443.
24. Fittipaldi A., Ferrari A., Zoppe' M., Arcangeli C., Pellegrini V., Beltram F., Giacca M. Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 tat fusion proteins. J. Biol. Chem. 278:2003;34141-34149.